As of February 2, 2024, the sentiment surrounding Quest Diagnostics (NYSE: DGX) among analysts is diverse. Over the past quarter, opinions have ranged from bullish to bearish, as indicated by 7 analysts. Let’s take a closer look at their recent ratings and how they compare to previous months:
– Bullish: 1 rating
– Somewhat Bullish: 0 ratings
– Indifferent: 6 ratings
– Somewhat Bearish: 0 ratings
– Bearish: 0 ratings
Within the last 30 days, there have been no bullish ratings, indicating a shift in sentiment. One month ago, there were no changes in ratings. Two months ago, there was one bullish rating, three indifferent ratings, and no bearish ratings. Three months ago, there were no bullish ratings, two indifferent ratings, and no bearish ratings.
The average 12-month price target for Quest Diagnostics is $146.57, with a high estimate of $160.00 and a low estimate of $137.00. This average has increased from the previous average price target of $139.71, suggesting a 4.91% rise.
Recent actions by analysts have involved adjustments to both ratings and price targets. For example, David Macdonald of Truist Securities initially lowered the “Hold” rating from $150.00 to $145.00, but later raised it back to $150.00 from $145.00. Derik De Bruin of B of A Securities raised the “Buy” rating from $140.00 to $160.00, and other analysts have made similar adjustments.
In summary, the analyst ratings for Quest Diagnostics exhibit a range of opinions, with a consensus of “Hold” based on the ratings of 10 Wall Street analysts. The average price target stands at $148.00, with a high forecast of $165.00 and a low forecast of $137.00. This suggests a potential upside of 13.95% from the current price.
Quest Diagnostics (DGX) Stock Performance Disappoints on February 2, 2024: Potential Downtrend and Concerns for Investors
On February 2, 2024, the stock performance of Quest Diagnostics (DGX) was closely monitored by investors and analysts. The data revealed that DGX was trading near the bottom of its 52-week range and was also below its 200-day simple moving average. These indicators hinted at a potential downtrend for the stock.
One of the key factors contributing to this downward trend was the recent price change in DGX shares. The stock had experienced a decrease of $2.17 since the market last closed, representing a 1.71% drop.
Closing at $125.00, DGX had reached a price level that was concerning for investors. The stock’s proximity to its 52-week low suggested that it may be undervalued, but it also raised concerns about the company’s financial performance and market sentiment.
To gain further insights, investors also observed the after-hours trading activity for DGX on February 2, 2024. Surprisingly, the stock remained unchanged during this period. While this stability could be seen as a positive sign, it also indicated that there was no immediate rebound in sight for DGX.
Overall, the stock performance of DGX on February 2, 2024, was disappointing, with the stock trading near its 52-week low and below its 200-day simple moving average. The decline of $2.17, equivalent to a 1.71% drop, had a negative impact on investor sentiment. The closing price of $125.00 and the lack of movement in after-hours trading further highlighted the challenges faced by DGX.
Investors and analysts will continue to closely monitor DGX’s performance in the coming days. The stock’s ability to rebound from its current position and regain momentum will be crucial for its future prospects.
DGX Stock Performance on February 2, 2024: Declines in Total Revenue, Net Income, and EPS Raise Concerns for Investors
DGX Stock Performance on February 2, 2024:
– Total revenue: $9.25 billion, a 6.38% decrease compared to the previous year. Revenue has remained flat since the last quarter.
– Net income: $850 million, a 9.77% decrease compared to the previous year. Net income declined by 13.9% since the last quarter.
– Earnings per share (EPS): $7.52, a 5.77% decrease compared to the previous year. EPS remained unchanged since the last quarter.
These declines in total revenue, net income, and EPS may be attributed to factors such as changes in market demand, competition, or internal operational challenges. Investors should closely monitor DGX’s financial performance and consider broader economic and industry-specific factors before making investment decisions.
